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Background: With increased longevity in the global aging population, joint health remains crit-
ical as the quality of life is increasingly associated with human mobility. Coupled with the grow-
ing focus on an active lifestyle, intervention procedures performed on the knee have been
gaining popularity, particularly the Anterior Cruciate Ligament (ACL) reconstruction. Such sur-
gical intervention often involves the use of tendon autografts, with semitendinosus and gracilis
tendons being popular choices. Nevertheless, less than optimal healing of the tendon graft within
the surgically created bone tunnel remains a fundamental problem in this procedure. The pro-
posed solution involves the application of a novel silk fibroin (SF) based sheath, embedded
with nanoparticles of low crystallinity hydroxyapatite (nHA), to complement the use of tendon
autografts and promote enthesis formation. This SF-nHA sheath configuration is tested against
SF sheaths with incorporation of bone morphogenetic protein 2 (BMP-2) only (SF-BMP2), a
blend of BMP-2 and nHA (SF-BMP2-nHA) and pure silk sheaths (pure SF) to evaluate their
potential in osteointegration of tendon grafts. The optimal sheath type was subsequently put
through an in depth assessment for biocompatibility and also in vivo study in a small and large
animal model for up to 9 months to evaluate the efficacy of the sheath in promoting osteointe-
gration of tendon grafts.
Materials and methods: Knitted SF scaffolds (240 fibroins, L30  Ø5 mm) were first fabricated
from raw Bombyx mori silk (Chul Thai Silk Co. Ltd) and subsequently degummed. The nHA
precipitates were synthesized by a co-participation method of aqueous (NH4)2HPO4 with aque-
ous Ca(NO3)2. Hydrothermal treatment of the precipitates' aqueous solution was carried out at
140 C under a pressure 0.3 MPa for 2 h in an autoclave to form the nanograde rod HA crystals.
SF sponges, made from a blend of aqueous SF solution (2% w/v) and synthesized nHA (12.9 mg/
ml), were incorporated to the knitted structures via a lyophilization process in a customized
mould. This SF-nHA group was compared with pure SF, SF-BMP2 (19.3 mg/ml BMP-2) and
SF-BMP2-nHA (19.3 mg/ml BMP-2 and 12.9 mg/ml nHA) via static culture of 10  10 mm
specimens with seeded porcine bone marrow derived MSCs (P2, 0.5  106/scaffold) over 28
days. Ex vivo static culture of the four groups of SF sheaths with tendon autografts (porcine
Flexor Digitorum Profundus sections, L10  Ø5 mm) and porcine bone marrow derived
MSCs (P2, 2  106/scaffold) was then conducted over 28 days. In these assessments, the cellular
viability, proliferation, gene expression, collagen deposition levels, scanning electron micro-
scopy (SEM) and histological analyses were performed (n ¼ 3). Consequently, the most effica-
cious group for osteointegration of tendon grafts was selected for the in depth biocompatibility
assessments and in vivo tests.
The complete optimized sheath was then tested through a series of biocompatibility assessment
for cytotoxicity, sensitization, intracutaneous reactivity, acute systemic and 14 days sub-chronic
repeated dose toxicity, genotoxicity (Ames test, chromosome aberration assay, mouse lymphoma
assay) and 12-weeks implantation in rabbit femur. A preclinical trial was conducted in the por-
cine ACL reconstruction model using tendon autograft harvested from the flexor digitorium pro-
fundus and SF-based sheath sutured onto both ends of the graft. Graft integration in the presence
of SF-based sheaths within the bone tunnels and tendon integrity within the intra-articular space
were assessed via imaging (CT and MRI), histomorphometrical and histopathological methods at
1, 3, 6 and 9 months time points. All animal experiments were approved by the respective institu-
tional IACUC.
Results: The SF sheaths were observed to be porous with interconnected pores. nHA and BMP-2
were observed to be securely incorporated in the lyophilized SF sponges. BMP-2 bioactivity was
ascertained after the fabrication process and was shown to be eluting with an initial burst release,
followed by a lowered sustained release.
MSCs were observed to be viable and proliferative in all four groups of the in vitro study.
Increased proliferations were observed in SF-nHA, SF-BMP2 and SF-BMP2-nHA at the early
phase (days 1-7) with an accelerated differentiation phase beginning from day 14. Consequently,
there was an upregulation of osteogenic related genes (Collagen I (Coll I), Collagen III (Coll III),
osteonectin (ON) and osteopontin (OPN)), leading to a significantly increased deposition of col-
lagen by day 21. However, it was further noted that between SF-nHA, SF-BMP2, and SF-BMP2-
nHA, the presence BMP-2 did not improve upon a persistent (beyond 21 days) upregulation of
osteogenic genes and increase in collagen production.
When cultured with excised tendon sections, it was observed that cells from within the tendon
tend not to participate in interfacial tissue regeneration, while seeded MSCs were viable and pro-
duced ECM for bridging the tendon-scaffold interface after 2 weeks in SF-nHA, SF-BMP2, and
SF-BMP2-nHA as observed via SEM and H&E staining images. SF sheaths with nHA stimu-
lated osteogenesis from seeded MSCs as observed by the presence of calcium deposits in SF-
nHA and SF-BMP2-nHA via alizarin red staining. Ossification was thus observed with the pres-
ence of nHA, with or without the presence of BMP-2.
Consequently, the SF-nHA sheath configuration was selected for further biocompatibility assess-
ment and in vivo testing. The SF-nHA sheath was found to induce discrete intracytoplasmic
granules with no cell lysis or reduction in cell growth in the tested mouse connective tissue
cell line (NCTC clone 929), indicating non-cytotoxicity. Sensitization tests indicated limited
erythema and oedema at challenged skin site over the 48 hours. There were also no significant
biological reactivity findings compared to the respective negative control groups in the acute sys-
temic and sub-chronic repeated dose toxicity assessments. Genotoxicity (Ames test) showed that
the sheath was non mutagenic in the tested bacterial strains of Salmonella typhimurium andEscherichia coli, while in vitro chromosome aberration test indicated that the sheath did not
induce structural chromosome aberration in the cultured mammalian somatic cells. Histopatho-
logical assessments of the extracted femurs of the 12 weeks implantation study indicated absence
of inflammatory cells with presence of neovascularization and bone ingrowth.
At 1 month post ACL reconstruction using the SF-based sheath with tendon autografts in the
preclinical porcine model, the reconstructed ACL became taut, when initially the tendon graft
was implanted slack. This indicated that there was simultaneous growth and graft remodeling
during this period. Regenerated epiligament was also formed, which provided vascularization
to the graft. It should be noted that the cartilage of the ACL reconstructed knee remained pristine
and clear of cartilage erosion, which was indicative of accelerated and enhanced joint stability
soon after the ACL reconstruction. The enhancement in osteointegration of tendon autograft was
evident as multiple small foci of mineralization were identified within the femoral and tibial ends
of the graft from as early as one month post ACL reconstruction. By 3 months, bone tissue infil-
tration into the interfacial space was evident from the increase in bone mineralization and vas-
cularized neotissue formation, indicating improved graft to bone integration comparing to
control (tendon autograft ACL reconstruction without SF-based sheath).
Discussion: Prompt osteointegration of the tendon graft within the bone tunnel post ACL recon-
struction was difficult with conventional therapies due to the lack of biochemical precursors.
These precursors are provided by the SF-based sheath, which also includes a temporary scaf-
folding material that helps to provide a snug fit to the bone interface. It will prevent micromo-
tion resulting in early inflammatory reactions, which can lead to the onset of fibrosis. The sheath
will also serve a delivery platform for cellular and bioactive components. Progenitor cells, either
seeded or attracted from the host into the porous sheath, will reconstitute the native cellular
environment of the enthesis by differentiating into chondrocytes and osteoblasts. They will
not only deposit the necessary ECM but also cytokines that elicit regenerative responses at
the integration site. The delivery of osteogenic factors via the SF-based sheath will accelerate
tissue restoration by triggering a migration of host reparative cells. These bioactive agents
will also induce cellular differentiation required for the formation of fibrocartilage and bony tis-
sue at the anchorage site.
Results from the in vitro study indicated that although BMP-2 led to earlier upregulation of
osteogenic genes, the expression of Coll I and ON were not significantly higher in SF-BMP2-
nHA by day 28 when compared with SF- nHA. In terms of protein production, collagen synthesis
between SF-nHA and SF-BMP2-nHA were not significant throughout the study, indicating that
even though SF-BMP2-nHA might have stimulated the targeted genotypic behavior, the pheno-
typic outcome was not significantly improved. This was further substantiated when the silk
sheaths were cultured with excised porcine tendons, whereby mineralized ECM could be found
after 4 weeks of culture in SF-nHA and SF-BMP2-nHA.
Balancing clinical needs and our in vitro and ex vivo findings, the SF-nHA sheath was selected
for further development. It was found that nHA stimulated tissue infiltration of host bone tissue,
resulting in bone tunnel narrowing with new mineralized tissues observed in both the small and
large animal models. Consequently, there was enhanced graft-to-host integration progressively
over the 9 months implantation period, which potentially resulted in overall mechanical proper-
ties closer to that of the native bone-ACL-bone construct.
Conclusion: Based on our knowledge, this study is the first to investigate a SF-based device to
augment ACL reconstruction with tendon autografts. With minimal disruption to current surgical
practice, the SF-based sheath exhibits clinical potential in accelerating healing to allow earlier
and more aggressive rehabilitation.
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Patello-femoral instability refers to any functional and/or anatomical abnormality within struc-
tures surrounding the patella and the femoral trochlea leading to knee pain, patellar subluxation,
dislocation and symptoms of patellar hypermobility.
There are four factors implied in patellofemoral instability: trochlear dysplasia, patella alta,
abnormal tibial tubercle-trochlear groove distance (TT-TG), and patellar tilt. Previous literature
has shown that trochlear dysplasia is the single most important factor implied in the genesis of
patellar instability, especially for habitual and recurrent dislocation (ref). However, the measure-
ment parameters used to define trochlea dysplasia show poor-to-fair inter and intra-observer cor-
relation. We aim to refine these parameters to develop a more reliable radiographic assessment of
patellofemoral instability.
We retrospectively evaluated the radiographs (CT patella tracking) of 120 patients with symp-
toms of patellofemoral instability (anterior knee pain, patella subluxation and dislocation), look-
ing specifically at trochlea dysplasia and how the sulcus angle varied with different degrees of
knee flexion and when measured at different parts of the patella. We also looked at how the sul-
cus angle was influenced by other factors such as the Wiberg classification of the patella and the
posterior condylar and transepicondylar lines. Lastly, we looked at the changes in the sulcus
angle after trochleoplasty and how the Dejour type influenced the type of trochleoplasty used.
Among 420 patients with clinical patellofemoral instability, 70 (16.7%) had bilateral patellofe-
moral instability, 190 (45.2%) had right-sided symptoms and 160 (38.1%) had left-sided symp-
toms. The predominant symptom was anterior knee pain (65%) followed by patella subluxation
(43%).
The average sulcus angle (per knee) measured at 0 flexion at the patella equator was 165.3 and
the average patella tilt at 0 flexion was 20.5. 92% of subjects had radiographic trochlea
